...
首页> 外文期刊>Oxidative Medicine and Cellular Longevity >Interplay between Nox2 Activity and Platelet Activation in Patients with Sepsis and Septic Shock: A Prospective Study
【24h】

Interplay between Nox2 Activity and Platelet Activation in Patients with Sepsis and Septic Shock: A Prospective Study

机译:脓毒症和脓毒症患者患者NOx2活性与血小板激活的相互作用:一项潜在研究

获取原文

摘要

Background. Although preclinical studies highlighted the potential role of NADPH oxidase (NOX) in sepsis, only few studies evaluated the oxidative stress in patients with sepsis and septic shock. The objective of the study is to appraise the oxidative stress status and platelet function in patients with sepsis and septic shock compared to healthy controls. Methods and Results. Patients with sepsis or septic shock admitted to the hospital Policlinico Umberto I (Sapienza University, Rome) underwent a blood sample collection within 1 hour from admission. Platelet aggregation, serum thromboxane B2 (TxB2), soluble NOX2-derived peptides (sNox2-dp), and hydrogen peroxide breakdown activity (HBA) were measured and compared to those of healthy volunteers. Overall, 33 patients were enrolled; of these, 20 (60.6%) had sepsis and 13 (39.4%) septic shock. Compared to healthy controls (n=10, age 67.8±3.2, male 50%), patients with sepsis and septic shock had higher platelet aggregation (49% (IQR 45-55), 60% (55.75-67.25), and 73% (IQR 69-80), respectively, p0.001), higher serum TxB2 (77.5 (56.5-86.25), 122.5 (114-131.5), and 210 (195-230) pmol/L, respectively, p0.001), higher sNox2-dp (10 (7.75-12), 19.5 (17.25-21), and 33 (29.5-39) pg/mL, respectively, p0.001), and lower HBA (75% (67.25-81.5), 50% (45-54.75), and 27% (21.5-32.5), respectively, p0.001). Although not statistically significant, a trend in higher levels of serum TxB2 and sNox2-dp in patients who died was observed. Conclusions. Patients with septic shock exhibit higher Nox2 activity and platelet activation than patients with sepsis. These insights joined to better knowledge of these mechanisms could guide the identification of future prognostic biomarkers and new therapeutic strategies in the scenario of septic shock.
机译:背景。虽然临床前研究强调了NADPH氧化酶(NOx)在败血症中的潜在作用,但少数研究评估了脓毒症和脓毒症休克患者的氧化胁迫。该研究的目的是评估与健康对照相比脓毒症和脓肠休克患者氧化应激状态和血小板功能。方法和结果。患有脓毒症或脓毒症休克的患者录取了医院Policlinico Umberto I(Sapienza大学,罗马)在入场后1小时内接受了血液样本收集。测定血小板聚集,血清血栓乳甲烷B2(TXB2),可溶性NOx2衍生的肽(SNOX2-DP)和过氧化氢分解活性(HBA),与健康志愿者的那些进行比较。总体而言,33名患者注册;其中,20(60.6%)患有败血症和13(39.4%)脓毒症休克。与健康对照(n = 10,年龄67.8±3.2,男性50%),脓毒症和脓毒症休克的患者具有更高的血小板聚集(49%(IQR 45-55),60%(55.75-67.25)和73% (IQR 69-80)分别为P <0.001),血清TXB2(77.5(56.5-86.25),122.5(114-131.5)和210(195-230)PMOL / L,P <0.001),更高的SnOx2-DP(10(7.75-12),19.5(17.25-21)和33(29.5-39)Pg / ml,P <0.001),低温(75%(67.25-81.5),50 %(45-54.75),分别为27%(21.5-32.5),P <0.001)。虽然没有统计学意义,但观察到死亡患者的血清TXB2和SNOX2-DP水平较高的趋势。结论。患有脓毒症休克的患者表现出高于败血症患者的NOX2活性和血小板活化。这些见解加入了更好地了解这些机制,可以指导在化脓性休克的情况下识别未来的预后生物标志物和新的治疗策略。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号